Prudential Financial Inc Gossamer Bio, Inc. Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 50,415 shares of GOSS stock, worth $130,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,415
Previous 47,050
7.15%
Holding current value
$130,574
Previous $51,000
21.57%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding GOSS
# of Institutions
152Shares Held
159MCall Options Held
2.91MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$47.5 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$46.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$31.1 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$20.9 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$18.5 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $243M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...